PRASAD RAYASAM S 4
4 · SANGSTAT MEDICAL CORP · Filed Sep 15, 2003
Insider Transaction Report
Form 4
PRASAD RAYASAM S
SVP WW Reg Affairs & Complianc
Transactions
- Exercise/Conversion
Common Stock
2003-09-11$21.10/sh+31,044$655,028→ 31,044 total - Exercise/Conversion
Options to Purchase Common Stock
2003-09-11$21.10/sh+31,044$655,028→ 0 totalExercise: $21.10From: 2003-09-11Exp: 2012-06-03→ Common Stock (31,044 underlying) - Exercise/Conversion
Common Stock
2003-09-11$21.10/sh+18,956$399,972→ 18,956 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−31,044$698,490→ 0 total - Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−18,956$426,510→ 0 total - Exercise/Conversion
Options to Purchase Common Stock
2003-09-11$21.10/sh+18,956$399,972→ 0 totalExercise: $21.10From: 2003-09-11Exp: 2012-06-03→ Common Stock (18,956 underlying)
Footnotes (1)
- [F1]Option vesting was accelerated and the underlying common stock and all other common stock owned by the reporting person was acquired by Genzyme Corporation ("Genzyme") pursuant to the Agreement and Plan of Merger by and among Genzyme, Swift Starboard Corporation and SangStat Medical Corporation.